Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04214119 | EsophaCap for the Detection of Early Esophageal Carcinoma | recruiting | — | 2,500 | Johns Hopkins UniversityOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT06085755 | Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer | recruiting | Phase 1 / Phase 2 | 61 | Jeeyun LeeOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| A Study of MT-4561 in Patients With Various Advanced Solid Tumors |
| recruiting |
| Phase 1 / Phase 2 |
| 27 |
| Tanabe Pharma America, Inc.INDUSTRY |
| 2 |
| Dec 11, 2025 |
| clinicaltrials |
| NCT07263386 | A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer(ARTEMIS-GC3) | recruiting | Phase 2 | 460 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05642819 | REVOLUTION Surgery (REVOLUTION Surgery) | recruiting | — | 200 | University of EdinburghOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT06333314 | Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI(Pan-MSI-ACSE) | recruiting | Phase 2 | 120 | UNICANCEROTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07139366 | Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment | recruiting | Phase 4 | 1,248 | Yongquan ShiOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07259226 | Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers(OASIS) | recruiting | Phase 2 | 400 | UNICANCEROTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07253948 | Distribution Characteristics of Helicobacter Pylori | recruiting | — | 231 | Jilin UniversityOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT06988475 | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07245095 | Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy(NACSIMET) | recruiting | Phase 2 | 132 | Hospital General de MexicaliOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06313801 | Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions | recruiting | Phase 2 | 106 | Nizhny Novgorod Regional Clinical Oncology CenterOTHER_GOV | 1 | Nov 21, 2025 | clinicaltrials |
| NCT06495645 | Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy | recruiting | N/A | 1,000 | The University of Hong KongOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT07149090 | Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites | recruiting | Phase 1 / Phase 2 | 61 | Asan Medical CenterOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT06759064 | Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites(IPIZA) | recruiting | Phase 1 / Phase 2 | 24 | Qilu Hospital of Shandong UniversityOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06222645 | PPG vs. ICG in Gastrointestinal Resections | recruiting | N/A | 200 | Saint Petersburg State University, RussiaOTHER | 2 | Nov 18, 2025 | clinicaltrials |
| NCT06675136 | Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases | recruiting | Phase 1 | 30 | City of Hope Medical CenterOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT06487221 | Avutometinib and Defactinib in Diffuse Gastric Cancer | recruiting | Phase 2 | 27 | Ryan H. Moy, MD, PhDOTHER | 1 | Nov 4, 2025 | clinicaltrials |
| NCT05880667 | Adaptive Radiation for Abdominopelvic Metastases | recruiting | Phase 1 | 30 | Fox Chase Cancer CenterOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | recruiting | — | 50,000 | Massive Bio, Inc.INDUSTRY | 2 | Oct 28, 2025 | clinicaltrials |
| NCT07103668 | A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients | recruiting | Phase 3 | 150 | Suzhou Immunofoco Biotechnology Co., LtdINDUSTRY | 1 | Oct 23, 2025 | clinicaltrials |
| NCT03551951 | Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow | recruiting | — | 320 | University of Missouri-ColumbiaOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT07212933 | The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial(RAK in GC) | recruiting | Phase 2 | 90 | Chinese PLA General HospitalOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT04780256 | Endoscopic Resection of Gastrointestinal Neoplasms | recruiting | — | 2,000 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Oct 3, 2025 | clinicaltrials |
| NCT00722228 | Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors | recruiting | Phase 1 / Phase 2 | 50 | Hadassah Medical OrganizationOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT07179692 | CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors | recruiting | Phase 1 | 108 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04809025 | Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer(EBPS) | recruiting | — | 510 | Fudan UniversityOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT06008054 | A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors | recruiting | Phase 2 | 376 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 26, 2025 | clinicaltrials |
| NCT07194005 | Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer(Remission) | recruiting | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT04710758 | Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer(CLASS-07) | recruiting | N/A | 1,018 | Shanghai Zhongshan HospitalOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT06253611 | First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer(BIG) | recruiting | Phase 2 | 120 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07183150 | The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer(Range of 4sb) | recruiting | — | 400 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT06500052 | A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors | recruiting | Phase 1 | 20 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07124351 | Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) | recruiting | Phase 4 | 15 | Cedars-Sinai Medical CenterOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT04665687 | Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients | recruiting | — | 1,730 | Samsung Medical CenterOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06796764 | COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: A Multicenter, Randomized, Controlled Clinical Trial | recruiting | N/A | 580 | Zhejiang UniversityOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT07102901 | Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma | recruiting | Phase 2 | 351 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Sep 10, 2025 | clinicaltrials |
| NCT07165847 | Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) | recruiting | Phase 2 | 40 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | recruiting | Phase 1 | 345 | Nurix Therapeutics, Inc.INDUSTRY | 2 | Sep 9, 2025 | clinicaltrials |
| NCT06783569 | A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors | recruiting | Phase 1 | 94 | JiaRay GroupINDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05180864 | Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer(OMEGA-2) | recruiting | N/A | 654 | Amsterdam UMCOTHER | 4 | Sep 4, 2025 | clinicaltrials |
| NCT06873659 | SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors | recruiting | Phase 1 | 96 | Qurgen Inc.INDUSTRY | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06728878 | Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer(zytg001) | recruiting | — | 150 | Jichao QinOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT06728891 | Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy(zypg001) | recruiting | — | 100 | Jichao QinOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT06736847 | Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer(zydgc001) | recruiting | — | 200 | Jichao QinOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT06768463 | Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer(CYGAS-GC) | recruiting | N/A | 250 | University Medical Center Ho Chi Minh City (UMC)OTHER | 1 | Aug 27, 2025 | clinicaltrials |
| NCT07018661 | [18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer(PLASTIC-3) | recruiting | Phase 2 / Phase 3 | 250 | Leiden University Medical CenterOTHER | 1 | Aug 27, 2025 | clinicaltrials |
| NCT07142122 | Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial(TLPG-CBVP) | recruiting | N/A | 76 | Fujian Cancer HospitalOTHER_GOV | 1 | Aug 26, 2025 | clinicaltrials |
| NCT06508307 | A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors | recruiting | Phase 1 | 21 | GONGCHU Biotechnology Co., LtdOTHER | 1 | Aug 21, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Dec 16, 2025source: clinicaltrials